資源描述：
《甲磺酸倍他司汀治療內(nèi)耳缺血相關(guān)性眩暈的療效研究.pdf》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。
1、FEATURE甲磺酸倍他司汀治療內(nèi)耳缺血相關(guān)性眩暈的療效研究TheeffectofbetahistinemesylateasatreatmenttovertigoinducedbyinnerearischemiaTheeffectofbetahistinemesylateasatreatmenttovertigoinducedbyinnerearischemia吳子明，張素珍，劉興健，陳艾婷，冀飛，楊偉炎，韓東一【摘要】目的通過觀察良性陣發(fā)性位置性眩暈（benignvertigoandtostudythecausalrelationsh
2、ipsofdosage.positionalparoxysmalvertigo，BPPV）、后循環(huán)缺血MethodNinetycasesofBPPV,PCIandMVwith30casefor（posteriorcirculationischemia，PCI）、偏頭痛性眩暈eachdiseasewererecruitedfortheexperiment.Patientswith（migrainousvertigo，MV）、青少年良性眩暈在服用不同eachdiseasewerethendividedinto2groups,15casein
3、劑量的甲磺酸倍他司汀后的臨床表現(xiàn)，了解甲磺酸倍他司汀eachgroup.Group1wastreatedwithbetahistinemesylate治療內(nèi)耳缺血性眩暈的療效。方法BPPV、PCI、MV各306mg3/d,Group2withbetahistinemesylate12mg3/d.例，分成2組。組一：甲磺酸倍他司汀6mg，3/日；組二：Twenty-?vepatientswithteenagerbenignparoxysmalvertigo甲磺酸倍他司汀12mg，3/日，治療均為期1個月。觀察量-效weregivenbet
4、ahistinemesylate,6mg3/dfordurationof1關(guān)系。青少年良性陣發(fā)性眩暈25例不分組，甲磺酸倍他司汀month.Highstimulatingrateofauditorybrainstemresponse6mg3/日，服藥治療1月。分別觀察治療前后高刺激聽性腦干(ABR)anddizzinesshandicapinventory(DHI)were測聽（auditorybrainstemresponse，ABR）和眩暈殘障程度administeredandcomparedbeforeandafteradmini
5、stration（dizzinesshandicapinventory，DHI）的變化。結(jié)果四類ofbetahistinemesylate.ResultsThesymptomsofthe眩暈治療后癥狀減輕，高刺激ABR和DHI均有改善，而眼動異patientswerereduced.BothhighstimulatingrateABRand常變化不明顯。連續(xù)用藥1個月后，BPPV、PCI、MV三類患DHIwereimproved,whereastheabnormalityofocular者12mg，3/日方案療效優(yōu)于6mg，3/日方案。
6、青少年良性眩motionremained.Onemonthaftertreatment,thetherapeutic暈6mg，3/日方案也獲得滿意療效。結(jié)論甲磺酸倍他司汀對protocolof12mg3/dwasbetterthanthatof6mg3/d.The良性陣發(fā)性位置性眩暈、后循環(huán)缺血、偏頭痛性眩暈和青少年protocolof6mg3/dfor1monthalsoindicatedsatisfactory良性眩暈等與內(nèi)耳低灌注有關(guān)的眩暈有較好的治療作用，并表treatmentresultsonteenagerbenignpar
7、oxysmalvertigo.現(xiàn)出量效關(guān)系，12mg，3/日方案療效優(yōu)于6mg，3/日方案。ConclusionThecurativeeffectofbetahistinemesylateon【關(guān)鍵詞】甲磺酸倍他司??；內(nèi)耳；缺血；眩暈BPPV,PCI,MVandteenagerbenignparoxysmalvertigowas【Abstract】ObjectiveToobservetheeffectofbetahistinesatisfactory.Thetherapeuticprotocolof12mg3/dwasmoremesyl
8、ateasatreatmenttobenignpositionalparoxysmaleffectivethanthatof6mg3/d.vertigo(BPPV),posteriorcirculation
